Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
Open Access
- 20 July 2015
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 125 (8) , 3132-3146
Abstract
Hereditary angioedema type III (HAEIII) is a rare inherited swelling disorder that is associated with point mutations in the gene encoding the plasma protease factor XII (FXII). Here, we demonstrate that HAEIII-associated mutant FXII, derived either from HAEIII patients or recombinantly produced, is defective in mucin-type Thr309-linked glycosylation. Loss of glycosylation led to increased contact-mediated autoactivation of zymogen FXII, resulting in excessive activation of the bradykinin-forming kallikrein-kinin pathway. In contrast, both FXII-driven coagulation and the ability of C1-esterase inhibitor to bind and inhibit activated FXII were not affected by the mutation. Intravital laser-scanning microscopy revealed that, compared with control animals, both F12–/– mice reconstituted with recombinant mutant forms of FXII and humanized HAEIII mouse models with inducible liver-specific expression of Thr309Lys-mutated FXII exhibited increased contact-driven microvascular leakage. An FXII-neutralizing antibody abolished bradykinin generation in HAEIII patient plasma and blunted edema in HAEIII mice. Together, the results of this study characterize the mechanism of HAEIII and establish FXII inhibition as a potential therapeutic strategy to interfere with excessive vascular leakage in HAEIII and potentially alleviate edema due to other causes.Keywords
This publication has 76 references indexed in Scilit:
- Ongoing Contact Activation in Patients with Hereditary AngioedemaPLOS ONE, 2013
- Hereditary angioedema: a bradykinin-mediated swelling disorderThrombosis and Haemostasis, 2013
- Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In VivoImmunity, 2011
- Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In VivoCell, 2009
- Hereditary AngioedemaNew England Journal of Medicine, 2008
- The elusive physiologic role of Factor XIIJournal of Clinical Investigation, 2008
- Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulationJournal of Clinical Investigation, 2008
- Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosisBlood, 2008
- Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type IIIThe American Journal of Human Genetics, 2006
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996